125 resultados para ISOENERGETIC TREATMENTS


Relevância:

20.00% 20.00%

Publicador:

Resumo:

Objectives: This study investigated the repairs of resin composite restorations after using different surface treatments.Design: Eighty four truncated cones of Filtek Z350 were prepared and thermo-cycled (20,000 cycles). Surfaces were roughened with diamond bur and etched with 37% phosphoric acid. Those cones were divided into 7 groups (N=12): 1) Prime&Bond 2.1; 2) aluminum oxide sandblasting+Prime&Bond 2.1; 3) Er:YAG laser treatment+Prime&Bond 2.1; 4) 9.6% hydrofluoric acid for 2 min-Fsilane coupling agent.; 5) silane coupling agent; 6) auto-polymerized acrylic monomer+Prime&Bond 2.1; 7) Adper Scothbond SE. Teflon device was used to fabricate inverted truncated cones of repair composite over the surface-treated. The bonded specimens were stressed to failure under tension. The data were analyzed with oneway ANOVA and Tukey tests.Results: Mean repair strengths (SD, in MPa) were, Group-2: 18.8a; Group-1: 18.7a; Group-6: 13.4ab; Group-7: 9.5bc; Group-3: 7.5bcd; Group-4: 5.2cd; Group-5: 2.6d.Conclusions: The use of diamond bur and a conventional adhesive and the use of aluminum oxide sandblasting prior to adhesive provided a simple and cost-effective solutions to composite repair. Er:YAG laser, silane alone, 9.6% hydrofluoric acid plus silane or a self-etching adhesive results in inferior composite repair strengths. (C) 2015 Elsevier Ltd. All rights reserved.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Relevância:

20.00% 20.00%

Publicador:

Resumo:

Peritonitis continues to be a major complication of peritoneal dialysis (PD), and adequate treatment is crucial for a favorable outcome. There is no consensus regarding the optimal therapeutic regimen, and few prospective controlled studies have been published. The objective of this manuscript is to review the results of PD peritonitis treatment reported in narrative reviews, systematic reviews, and proportional meta-analyses. Two narrative reviews, the only existing systematic review and its update published between 1991 and 2014 were included. In addition, we reported the results of a proportional meta-analysis published by our group. Results from systematic reviews of randomized control trials (RCT) and quasi-RCT were not able to identify any optimal antimicrobial treatment, but glycopeptide regimens were more likely to achieve a complete cure than a first generation cephalosporin. Compared to urokinase, simultaneous catheter removal and replacement resulted in better outcomes. Continuous and intermittent IP antibiotic use had similar outcomes. Intraperitoneal antibiotics were superior to intravenous antibiotics in reducing treatment failure. In the proportional meta-analysis of RCTs and the case series, the resolution rate (86%) of ceftazidime plus glycopeptide as initial treatment was significantly higher than first generation cephalosporin plus aminoglycosides (66%) and glycopeptides plus aminoglycosides (75%). Other comparisons of regimens used for either initial treatment or treatment of gram-positive rods or gram-negative rods did not show statistically significant differences. The superiority of a combination of a glycopeptide and a third generation cephalosporin was also reported by a narrative review study published in 1991, which reported an 88% resolution rate.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

The granulomatous lesions are frequently founded in infectious diseases and can involve the larynx and pharynx and can cause varying degrees of dysphonia and dysphagia. There is still no systematic review that analyzes effectiveness of speech therapy in systemic granulomatous diseases. Research strategy: A systematic review was performed according to Cochrane guideline considering the inclusion of RCTs and quasi-RCTs about the effectiveness of speech-language therapy to treat dysphagia and dysphonia symptoms in systemic granulomatous diseases of the larynx and pharynx. Selection criteria: The outcome planned to be measured in this review were: swallowing impairment, frequency of chest infections and voice and swallowing symptoms. Data analysis: We identified 1,140 citations from all electronic databases. After an initial shift we only selected 9 titles to be retrieved in full-text. After full reading, there was no RCT found in this review and therefore, we only described the existing 2 case series studies. Results: There were no randomized controlled trials found in the literature. Therefore, two studies were selected to be included only for narratively analysis as they were case series. Conclusion: There is no evidence from high quality studies about the effectiveness of speech-language therapy in patients with granulomatous diseases of the larynx and pharynx. The investigators could rely in the outcomes suggested in this review to design their own clinical trials.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

Based on fish production performance, this study assessed the feasibility of replacing SBM with CSM in practical diets for cage-raised Nile tilapia during the finishing phase. To accomplish this research, four isoproteic (32% CP) and isoenergetic (2500 Kcal/kg of DE) diets were formulated. Control diet (T1) contained 30 % of SBM and 0% of CSM. The other three diets contained: 20% of SBM and 10% of CSM (T2), 10% of SBM and 20% of CSM (T3) and 0% of SBM and 30% of CSM (T4). Lysine and Methionine deficiency was compensated for with synthetic amino acid (L-lysine and DL- methionine) supplementation. Experimental design was completely randomized with four treatments and four repetitions. Data were analyzed with SAS PROC GLM through co-variance analysis, adding initial mean weight as a co-variable, followed by Dunnett test. The system used to calculate the profit part was Partial Budget Analysis in Aquaculture, proposed by Shang (1990). Profit was significantly different at T3 when compared to T1 (control). It was concluded that the addition of 20% of CSM to finishing diets can improve cage-raised Nile tilapia profitability.